Galedra
Sign in Sign up

Source

Accessing clinical trial information via two social media platforms: the new normal for patients and stakeholders PRIMARY_TEXT retrieval pending

Scientific Reports · 2026-09-18 · no page hash: the reader saw a rendering, not the bytes · created seq 16731

Link: https://www.nature.com/articles/s41598-026-71633-9.pdf · read at 2026-09-29T00:51:25Z · held by reference: only the link, the quoted excerpts with their hashes, and the page hash when the reader had the bytes are stored

Retrieval by Galedra

BLOCKED at 2026-09-29T01:21:02Z · https://idp.nature.com/authorize?response_type=cookie&client_id=grover&redirect_uri=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41598-026-71633-9 · seq 18311

Claims from this source

No claims have been extracted from this source yet.

Locations

LocatorExcerpt
QUOTE {}Two datasets were analysed: Bluesky posts (January–May 2025, n = 8849) and Twitter (X) posts (June 25–30, 2025, n = 5520). Due to differences in data accessibility across platforms, the datasets are not temporally equivalent and are inte...
QUOTE {}The analysis indicates that Bluesky discourse was more cohesive and research-oriented, with a relatively more specialised vocabulary. In contrast, Twitter (X) exhibited more fragmented and event-driven communication patterns, along with ...

Claims citing this source